Skip to main content
Joint inflammation drug may be repurposed to treat Covid-19: Study - Hindustan Times 12-Jun-2020
Joint inflammation drug may be repurposed to treat Covid-19: Study - Hindustan Times
Researchers, including those from Imperial College London in the UK, noted that baricitinib is an oral drug used for treatment of adult patients with moderate to severe rheumatoid arthritis -- a chronic inflammatory disorder which affects the joints, causing …
More...